Immulus Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Immulus General Information

Description

Developer of a good manufacturing process (GMP) intended to expand T-cells for drug development selectively. The company is currently operating in Stealth mode.

Contact Information

Website
www.immulus.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2945 Webster Street
  • Oakland, CA 94609
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 2945 Webster Street
  • Oakland, CA 94609
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Immulus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Nov-2020 Completed Stealth
4. Early Stage VC 23-May-2020 Completed Stealth
3. Accelerator/Incubator 01-Jan-2020 Completed Stealth
2. Early Stage VC 01-Jan-2019 Completed Stealth
1. Accelerator/Incubator 01-Jan-2019 Completed Stealth
To view Immulus’s complete valuation and funding history, request access »

Immulus Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Axial (San Francisco) Venture Capital Minority
Blue Bear Ventures Venture Capital Minority
California Life Sciences Accelerator/Incubator Minority
Innovation Partnerships Venture Capital Minority
Lyell Immunopharma Corporation Minority
To view Immulus’s complete investors history, request access »

Immulus FAQs

  • When was Immulus founded?

    Immulus was founded in 2019.

  • Where is Immulus headquartered?

    Immulus is headquartered in Oakland, CA.

  • What industry is Immulus in?

    Immulus’s primary industry is Biotechnology.

  • Is Immulus a private or public company?

    Immulus is a Private company.

  • What is Immulus’s current revenue?

    The current revenue for Immulus is .

  • Who are Immulus’s investors?

    Axial (San Francisco), Blue Bear Ventures, California Life Sciences, Innovation Partnerships, and Lyell Immunopharma have invested in Immulus.

  • When was Immulus acquired?

    Immulus was acquired on 01-Nov-2020.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »